On July 16th, S&P Global released its Sustainability Yearbook China 2024, recognizing and commending Chinese enterprises that demonstrate sustainable development leadership within their industries. Mindray, a leading global provider of medical devices and solutions, has made the list for the first time.
This marks the second consecutive year that S&P Global has published the Sustainability Yearbook China. Over 1,700 Chinese companies were evaluated, with 129 ultimately being selected. To qualify for inclusion, companies must rank within the top 15% of their industry by number and achieved a minimum CSA Score above 30 and falling within 30% of that industry’s top performing company.
Mindray published its sixth annual sustainability report this year, highlighting the company's initiatives and achievements in ESG management. The company continues to enhance its sustainable development management system, integrating ESG principles into every aspect of its value chain.
Mindray's MSCI ESG rating has been elevated to AA, and it was recognized with the EcoVadis 2023 Silver Medal for sustainability efforts. In climate-related CDP assessment, the company has advanced to a B management level.
Mindray remains committed to advancing sustainable development through a robust governance framework and a globally diverse talent pool. It continues to strengthen capabilities in R&D innovation, supply chain resilience, and market responsiveness, aiming to enhance customer service and accessibility to high-quality healthcare services worldwide.